Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB08820_nanopub.RAHRMw9oI5XIlYuFCG1HS6vUwxP8H0nc3lJl3EAY23J5k#assertion>. }
Showing items 1 to 20 of
20
with 100 items per page.
- drugbank:DB08820 type drugbank_vocabulary:Drug assertion.
- drugbank:DB08820 label "Ivacaftor [drugbank:DB08820]" assertion.
- drugbank:DB08820 seeAlso DB08820 assertion.
- drugbank:DB08820 seeAlso kalydeco.html assertion.
- drugbank:DB08820 seeAlso kalydeco-drug.htm assertion.
- drugbank:DB08820 identifier "drugbank:DB08820" assertion.
- drugbank:DB08820 description "Ivacaftor (also known as Kalydeco or VX-770) is a drug for the treatment of cystic fibrosis, developed by Vertex Pharmaceuticals and the Cystic Fibrosis Foundation. FDA approved on January 31, 2012." assertion.
- drugbank:DB08820 title "Ivacaftor" assertion.
- drugbank:DB08820 bio2rdf_vocabulary:identifier "DB08820" assertion.
- drugbank:DB08820 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB08820 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB08820" assertion.
- drugbank:DB08820 bio2rdf_vocabulary:x-identifiers.org DB08820 assertion.
- drugbank:DB08820 drugbank_vocabulary:drugbank-id "DB08820" assertion.
- drugbank:DB08820 drugbank_vocabulary:x-cas cas:873054-44-5 assertion.
- drugbank:DB08820 drugbank_vocabulary:x-ahfs ahfs:48:92 assertion.
- drugbank:DB08820 drugbank_vocabulary:x-atc atc:R07AX02 assertion.
- drugbank:DB08820 drugbank_vocabulary:x-chebi chebi:66901 assertion.
- drugbank:DB08820 drugbank_vocabulary:x-kegg kegg:D09916 assertion.
- drugbank:DB08820 drugbank_vocabulary:x-wikipedia wikipedia:Ivacaftor assertion.
- drugbank:DB08820 drugbank_vocabulary:x-ndc ndc:51167-200-01 assertion.